Chuanyong Liu
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
- Immunology top 10%
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 2
-
- Lung Cancer Treatments and Mutations 2
-
- Pregnancy and preeclampsia studies 1
-
- Moyamoya disease diagnosis and treatment 1
-
- Neurological Complications and Syndromes 1
- Co-authors
- Yuping SunJie LiuMeili SunHuan ShiXianqiang LiuAiqin GaoPei ZhangYue Ma
- Partner nations
- China
In The Last Decade
Chuanyong Liu
17 papers receiving 546 citations
Peers
Comparison fields: 5 of 74
- Oncology 329
- Immunology 225
- Water Science and Technology 51
- Cancer Research 39
- Pollution 27
Countries citing papers authored by Chuanyong Liu
This map shows the geographic impact of Chuanyong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanyong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanyong Liu more than expected).
Fields of papers citing papers by Chuanyong Liu
This network shows the impact of papers produced by Chuanyong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanyong Liu. The network helps show where Chuanyong Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chuanyong Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 4 | |
| 3 | 2021 | 16 | |
| 4 | 2018 | 15 | |
| 5 | Antitumor effects and persistence of a novel HER2 CAR T cells directed to gastric cancer in preclinical models. | 2018 | 51 |
| 6 | A Time-Saving Method to Prepare Monodisperse Fe3O4 Microspheres with Controllable Sizes and Morphologies | 2017 | 1 |
| 7 | 2017 | 1 | |
| 8 | 2017 | 11 | |
| 9 | 2016 | 18 | |
| 10 | 2015 | 60 | |
| 11 | B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer. | 2015 | 63 |
| 12 | 2014 | 26 | |
| 13 | 2014 | 103 | |
| 14 | 2012 | 55 | |
| 15 | 2011 | 11 | |
| 16 | 2010 | 71 | |
| 17 | 2008 | 45 |
About Chuanyong Liu
Chuanyong Liu is a scholar working on Oncology, Immunology and Immunology and Allergy, having authored 17 papers that have together received 553 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Lung Cancer Treatments and Mutations (2 papers), Pregnancy and preeclampsia studies (1 paper), Moyamoya disease diagnosis and treatment (1 paper) and Neurological Complications and Syndromes (1 paper). The work is most often cited by research in Oncology (329 citations), Immunology (225 citations) and Water Science and Technology (51 citations). Chuanyong Liu has collaborated with scholars based in China. Frequent co-authors include Yuping Sun, Jie Liu, Meili Sun, Huan Shi, Xianqiang Liu, Aiqin Gao, Pei Zhang, Yue Ma, Xiao‐Ming Li and Baoyu Gao. Their work appears in journals such as FEBS Letters, CHEST Journal and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.